|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1998-9-22
|
|
pubmed:abstractText |
Previous studies demonstrated that doxorubicin and vinorelbine combinations in first-line chemotherapy are highly active in metastatic breast cancer. Mitoxantrone is an anthracenedione with low cardiotoxicity, and seems to be effective when combined with vinorelbine after prior exposure to anthracyclines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
384-90
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9732214-Adult,
pubmed-meshheading:9732214-Aged,
pubmed-meshheading:9732214-Anthracyclines,
pubmed-meshheading:9732214-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9732214-Breast Neoplasms,
pubmed-meshheading:9732214-Humans,
pubmed-meshheading:9732214-Middle Aged,
pubmed-meshheading:9732214-Mitoxantrone,
pubmed-meshheading:9732214-Neoplasm Metastasis,
pubmed-meshheading:9732214-Salvage Therapy,
pubmed-meshheading:9732214-Survival Analysis,
pubmed-meshheading:9732214-Vinblastine
|
|
pubmed:articleTitle |
First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study.
|
|
pubmed:affiliation |
Department of Medicine, Institut Gustave- Roussy, Villejuif, France. ALLCPB64@teleline.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
